CorMedix
CRMD
91 hedge funds and large institutions have $73.3M invested in CorMedix in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 34 reducing their positions, and 18 closing their positions.
3% more capital invested
Capital invested by funds: $71.4M → $73.3M (+$1.86M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.22% less ownership
Funds ownership: 34.65% → 31.43% (-3.2%)
10% less funds holding
Funds holding: 101 → 91 (-10)
32% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 34
56% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 18
59% less call options, than puts
Call options by funds: $746K | Put options by funds: $1.82M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$357K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$263K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
+$230K |
| 4 |
State Street
Boston,
Massachusetts
|
+$127K |
| 5 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$109K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$1.35M |
| 2 |
Morgan Stanley
New York
|
-$1.06M |
| 3 |
Millennium Management
New York
|
-$961K |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$748K |
| 5 |
Two Sigma Investments
New York
|
-$398K |
CRMD Hedge Fund Activity: Q1 2024 in Review
91 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q1 2024, worth a combined $73.3M — up 2.6% from $71.4M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of CRMD and 8 opened new positions — a net loss of 10 holders — while 34 trimmed existing stakes and 23 added.
The largest buyer was Vanguard Group, adding an estimated $357K. The largest seller was Marshall Wace, cutting an estimated $1.35M.
- 91 institutional investors held CorMedix (CRMD) as of Q1 2024, down from 101 in Q4 2023.
- Funds reported $73.3M of CorMedix stock for Q1 2024, up 2.6% quarter-over-quarter.
- 8 funds opened new CorMedix positions in Q1 2024 and 18 closed out, a net change of -10 holders.
- The largest CorMedix buyer in Q1 2024 was Vanguard Group, an estimated $357K added.
- The largest CorMedix seller in Q1 2024 was Marshall Wace, an estimated $1.35M sold.
Based on aggregated 13F filings for Q1 2024.